Utility of inflammatory markers to predict adverse outcome in acute pancreatitis: A retrospective study in a single academic center.
Acute complicated pancreatitis
lymphocytes to monocyte ratio
neutrophil to lymphocyte ratio
Journal
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
ISSN: 1998-4049
Titre abrégé: Saudi J Gastroenterol
Pays: India
ID NLM: 9516979
Informations de publication
Date de publication:
21 Jul 2020
21 Jul 2020
Historique:
entrez:
29
7
2020
pubmed:
29
7
2020
medline:
29
7
2020
Statut:
aheadofprint
Résumé
Acute pancreatitis (AP) is a commonly encountered emergency where early identification of complicated cases is important. Inflammatory markers like lymphocyte to monocyte ratio (LMR) and neutrophil to lymphocyte ratio (NLR) are simple and readily available markers. In this study, we evaluated the utility of these markers in the early identification of patients with complicated AP. All patients with a diagnosis of AP admitted to the University Medical Center in Las Vegas/Nevada between August 2015 and September 2018 were identified using ICD-10 codes. Medical records were reviewed retrospectively. Epidemiological measures and their associated confidence intervals were calculated using MedCalc (v. 18). The LMR showed a significant difference between groups, with the non-complicated cases consistently higher than the complicated cases but without significant temporal differences. The NLR showed a significant difference with a significant temporal relation. Using the bound of the 95% confidence interval separating the two groups, LMR <2 was found to be associated with a complicated case and NLR >10.5 was suggestive of a complicated case. High specificity (85-92%) with low sensitivity (23-69%) was noted; hence, these cut points were very good at discerning non-complicated cases. Our data show persistently low LMR that is associated with severe AP and a value of <2.0 can be used clinically to predict severe AP on admission. It also shows that elevated NLR is associated with complicated AP and prolonged hospital stay with a value >10.5 that can be used to predict severe complicated AP and to monitor response to treatment over time.
Sections du résumé
BACKGROUND/AIM
OBJECTIVE
Acute pancreatitis (AP) is a commonly encountered emergency where early identification of complicated cases is important. Inflammatory markers like lymphocyte to monocyte ratio (LMR) and neutrophil to lymphocyte ratio (NLR) are simple and readily available markers. In this study, we evaluated the utility of these markers in the early identification of patients with complicated AP.
PATIENTS AND METHODS
METHODS
All patients with a diagnosis of AP admitted to the University Medical Center in Las Vegas/Nevada between August 2015 and September 2018 were identified using ICD-10 codes. Medical records were reviewed retrospectively. Epidemiological measures and their associated confidence intervals were calculated using MedCalc (v. 18).
RESULTS
RESULTS
The LMR showed a significant difference between groups, with the non-complicated cases consistently higher than the complicated cases but without significant temporal differences. The NLR showed a significant difference with a significant temporal relation. Using the bound of the 95% confidence interval separating the two groups, LMR <2 was found to be associated with a complicated case and NLR >10.5 was suggestive of a complicated case. High specificity (85-92%) with low sensitivity (23-69%) was noted; hence, these cut points were very good at discerning non-complicated cases.
CONCLUSION
CONCLUSIONS
Our data show persistently low LMR that is associated with severe AP and a value of <2.0 can be used clinically to predict severe AP on admission. It also shows that elevated NLR is associated with complicated AP and prolonged hospital stay with a value >10.5 that can be used to predict severe complicated AP and to monitor response to treatment over time.
Identifiants
pubmed: 32719240
pii: 290343
doi: 10.4103/sjg.SJG_49_20
pmc: PMC7580735
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
None
Références
J Natl Cancer Inst. 2014 May 29;106(6):dju124
pubmed: 24875653
Gastroenterology. 2010 Sep;139(3):813-20
pubmed: 20540942
Oncologist. 2019 Nov;24(11):e1123-e1131
pubmed: 30952822
Am J Emerg Med. 2013 Apr;31(4):687-9
pubmed: 23399348
Arch Ital Urol Androl. 2019 Jan 17;90(4):270-275
pubmed: 30655640
Ulus Travma Acil Cerrahi Derg. 2019 Mar;25(2):177-182
pubmed: 30892679
Ann Surg Oncol. 2011 Nov;18(12):3362-9
pubmed: 21547702
Crit Rev Clin Lab Sci. 2015;52(6):273-83
pubmed: 26173077
World J Surg. 2008 Aug;32(8):1757-62
pubmed: 18340479
Gastroenterol Clin North Am. 2007 Jun;36(2):277-96, viii
pubmed: 17533079
Basic Clin Pharmacol Toxicol. 2005 Dec;97(6):342-50
pubmed: 16364048
J Surg Oncol. 2005 Sep 1;91(3):181-4
pubmed: 16118772
Intensive Care Med. 2015 Nov;41(11):1957-60
pubmed: 26077091
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
Lancet. 1974 Apr 20;1(7860):701-3
pubmed: 4132422
Ann Surg Oncol. 2020 Mar;27(3):844-852
pubmed: 31720937
J Gastrointest Surg. 2013 Apr;17(4):675-81
pubmed: 23371356
BMJ Open. 2014 Aug 05;4(8):e004721
pubmed: 25095875
Bratisl Lek Listy. 2001;102(1):5-14
pubmed: 11723675
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Am Heart J. 2007 Nov;154(5):995-1002
pubmed: 17967611
Crit Care. 2010;14(5):R192
pubmed: 21034463
Medicine (Baltimore). 2016 Sep;95(37):e4746
pubmed: 27631223